Influence of Vitamin D on Inflammatory Bowel Disease Remission

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01121796
Recruitment Status : Unknown
Verified May 2010 by Hillel Yaffe Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : May 12, 2010
Last Update Posted : May 12, 2010
Technion, Israel Institute of Technology
Information provided by:
Hillel Yaffe Medical Center

Brief Summary:
Vitamin D has been shown to influence a multitude of systems. We intend to see whether different types of Vitamin D supplements have an effect on inflammatory bowel disease.

Condition or disease Intervention/treatment
Inflammatory Bowel Disease Dietary Supplement: Vitamin D Other: Water or milk Dietary Supplement: Vitamin D enriched milk

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 90 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Care Provider)
Primary Purpose: Treatment
Study Start Date : June 2010
Estimated Primary Completion Date : June 2011

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Vitamin D
Drug Information available for: Vitamin D
U.S. FDA Resources

Arm Intervention/treatment
Active Comparator: Vitamin D Dietary Supplement: Vitamin D
Placebo Comparator: Placebo Other: Water or milk
Active Comparator: Unique vehicle for Vitamin D supplementation Dietary Supplement: Vitamin D enriched milk

Primary Outcome Measures :
  1. Inflammatory disease remission [ Time Frame: One year ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Mild to moderate inflammatory bowel disease

Exclusion Criteria:

  • Hypersensitivity to milk products

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01121796

Contact: Zvi Fireman, MD
Contact: Oren Atia, MD

Hillel Yaffe Medical Center Not yet recruiting
Hadera, Israel, 38100
Sponsors and Collaborators
Hillel Yaffe Medical Center
Technion, Israel Institute of Technology

Responsible Party: Dr. Zvi Fireman, Director Gastroenterology Institute, Hillel Yaffe Medical Center Identifier: NCT01121796     History of Changes
Other Study ID Numbers: HY100510
First Posted: May 12, 2010    Key Record Dates
Last Update Posted: May 12, 2010
Last Verified: May 2010

Additional relevant MeSH terms:
Intestinal Diseases
Inflammatory Bowel Diseases
Gastrointestinal Diseases
Digestive System Diseases
Vitamin D
Growth Substances
Physiological Effects of Drugs
Bone Density Conservation Agents